Martin Shkreli Says on Twitter He May Testify on Drug PricesBy
Former Turing CEO took the Fifth last time he visited Congress
Executive says he has ‘lots of insight’ into price controversy
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals AG, may appear before Congress to testify on drug pricing.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.